Since PTHS individuals were found to have low IgM levels and TCF4 targets several immunoglobulin enhancer sites, it has been suggested that long-term follow-up is needed to evaluate susceptibility to infections, autoimmune disorders and tumours [10]. The gene discussed is TCF4; the disease is Pitt-Hopkins syndrome.